# Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)

> **NCT03812302** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 9 (actual)

## Conditions studied

- Giant Cell Arteritis

## Interventions

- **DIAGNOSTIC_TEST:** 68-Ga HA-DOTATATE PET/CT

## Key facts

- **NCT ID:** NCT03812302
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-09
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03812302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03812302, "Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03812302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*